Inogen Inc 8-K

What Happened

• On June 5, 2026, Inogen, Inc. held its annual meeting. Stockholders approved the Amended and Restated 2023 Equity Incentive Plan, which increases the shares available for awards by 750,000 and became effective immediately upon approval. The meeting also elected Class III directors and ratified Deloitte & Touche LLP as the company's independent auditor.

Key Details

• Record and turnout: 27,324,616 shares were entitled to vote (record date April 6, 2026); 20,844,941 shares (≈76.28%) were represented at the meeting.
• Equity plan: Approval adds 750,000 shares to the company’s 2023 Equity Incentive Plan; plan documents and standard award agreement forms are filed as exhibits to the 8-K.
• Director elections: Glenn Boehnlein was elected with 17,324,463 votes for (948,762 withheld; 2,571,716 broker non‑votes). Mira Sahney was elected with 13,276,829 votes for (4,996,396 withheld; 2,571,716 broker non‑votes).
• Other votes: Deloitte ratified as auditor (20,395,716 for; 407,035 against). Advisory vote on executive compensation passed (17,316,134 for; 921,787 against). Proposal to declassify the board failed (17,883,761 for; 154,379 against).

Why It Matters

• For investors, the approved equity plan increases the pool of shares available for employee and executive awards, which can lead to future dilution as grants are issued. The filing confirms the board remains classified (the declassification amendment failed), so director turnover will continue on a staggered schedule. Ratification of Deloitte maintains continuity in the company’s auditor.